The prevalence of Clostridioides difficile infections decreased during the COVID-19 pandemic, but inpatient mortality and treatment costs went up, a study published Aug. 25 in Open Forum Infectious Diseases found.
Read the full post on Becker's Hospital Review - Healthcare News
